Difficulty: Medium
Average Score: 92%
Practice
You are evaluating a 6-mo-old girl with a firm right suprarenal mass. Histologically, there is no bony involvement, 10% bone marrow involvement, subcutaneous nodules involvement, and massive abdominal mass. The N-myc oncogene is not amplified. According to the international neuroblastoma staging system, the infant is stratified as
Correct answer
D
Rationale
In this scenario, the correct answer is D) stage IV S. The key to determining the correct stage lies in the extent of disease spread. Stage IV neuroblastoma is characterized by the presence of distant metastasis, which is evident in this case with the massive abdominal mass, subcutaneous nodules involvement, and bone marrow involvement. The absence of N-myc oncogene amplification is also a crucial factor in the staging process.
Option A) stage I is incorrect because there is clear evidence of distant metastasis in this case. Option B) stage II A is incorrect as it does not encompass the extensive disease involvement seen in this patient. Option C) stage III is also incorrect as it does not reflect the presence of distant metastasis as seen in this case.
From an educational perspective, understanding the international neuroblastoma staging system is crucial for healthcare providers involved in the care of pediatric oncology patients. It aids in determining prognosis, guiding treatment decisions, and facilitating communication among healthcare teams. This case underscores the importance of a comprehensive evaluation and knowledge of staging criteria in managing pediatric oncology cases effectively.
Option A) stage I is incorrect because there is clear evidence of distant metastasis in this case. Option B) stage II A is incorrect as it does not encompass the extensive disease involvement seen in this patient. Option C) stage III is also incorrect as it does not reflect the presence of distant metastasis as seen in this case.
From an educational perspective, understanding the international neuroblastoma staging system is crucial for healthcare providers involved in the care of pediatric oncology patients. It aids in determining prognosis, guiding treatment decisions, and facilitating communication among healthcare teams. This case underscores the importance of a comprehensive evaluation and knowledge of staging criteria in managing pediatric oncology cases effectively.